Medical Device Contract Manufacturing Market

Medical Device Contract Manufacturing Market Size by Device Type (IVD, Cardiovascular, Drug Delivery (Autoinjectors, Infusion Device), Diabetes Care, Orthopedic, Ophthalmology, Endoscopy, Surgical), Device Class (I, II, III), Services & Region - Global Forecast to 2029

Report Code: MD 7111 Mar, 2024, by marketsandmarkets.com

The size of global medical device contract manufacturing market in terms of revenue was estimated to be worth $78.9 billion in 2024 and is poised to reach $149.4 billion by 2029, growing at a CAGR of 11.4% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

Medical device contract manufacturing is rapidly transforming the industry, offering significant advantages for manufacturers. Industry 4.0 includes integration of automation, robotics, and data analytics in MDCM enhances production efficiency, precision, and consistency. Additive manufacturing (3D printing) technology allows for the creation of complex and customized medical devices, expanding the possibilities for innovative solutions which is expected drive the medical device contract manufacturing.

Medical Device Contract Manufacturing Market Size, Dynamics & Ecosystem

Medical Device Contract Manufacturing Market Size, Dynamics & Ecosystem

To know about the assumptions considered for the study, Request for Free Sample Report

Medical device contract manufacturing market Dynamics

Driver: Rising aging population

Life expectancy is increasing globally, while birth rates are declining in many countries. This leads to a larger proportion of older adults in the population pyramid, the United Nations reports that the global population aged 60 years or over is projected to nearly double from 1 billion in 2020 to 2.1 billion by 2050 an aging population creates a higher demand for healthcare services, particularly those related to age-related conditions like dementia, heart disease, and chronic illnesses which is expected to drive the market growth.

Restraint: Stringent regulatory guidelines for medical devices.

Devices are categorized based on their level of potential risk to patients (e.g., Class I - low risk, Class III - high risk). Stringency of regulations increases with higher risk classifications, manufacturers must demonstrate a documented and controlled design process that adheres to safety and performance standards further manufacturers are obligated to monitor their devices after they reach the market and report any adverse events which is expected to restrain the market growth.

Opportunity: Potential for growth in emerging countries

The potential for medical device contract manufacturing in emerging countries is significant, offering exciting opportunities for improved diagnostic devices access and enhanced treatment approaches. Emerging economies are experiencing rapid population growth, leading to an increased demand for healthcare services and medical devices. A burgeoning middle class with rising disposable income creates a larger consumer base willing to spend on advanced medical treatments and technologies. Governments in emerging countries are increasingly allocating resources towards improving healthcare accessibility and affordability. This can involve subsidies for medical devices or promoting local manufacturing which is expected to create opportunities for the growth of the market.

Challenge: Lack of constant innovation to balance technological capabilities against costs

High costs of innovation which includes expensive materials, complex manufacturing processes, and extensive clinical trials also strict regulatory guidelines necessitate rigorous testing and data collection, further adding to the overall cost of bringing new devices to market. The substantial investment required for innovation can translate to higher priced medical devices. This can limit accessibility for patients, especially in regions with limited resources which is expected to challenge the market growth.

The medical device contract manufacturing market is becoming increasingly competitive, with new players entering the market and established players vying for market share. This competition drives down prices as companies try to undercut each other. The cost of materials, equipment, and labor is increasing, putting pressure on dental businesses to maintain profitability while keeping prices competitive. Consolidation within the dental industry, particularly the rise of dental laboratories creates larger entities with greater purchasing power. This can lead to lower prices for supplies and equipment, further pressuring smaller players also government regulations and changes in insurance coverage can impact reimbursement rates for dental procedures, forcing providers to adjust their pricing strategies

Medical Device Contract Manufacturing Market Segmentation & Geographical Spread

Medical Device Contract Manufacturing Market Segmentation & Geographical Spread

To know about the assumptions considered for the study, download the pdf brochure

By class of devices, class III is expected to show the highest CAGR of medical device contract manufacturing industry from 2024 to 2029.

The class of device segment is segmented into class I, class II and class III devices.

Class III devices are often critical for treating life-threatening conditions or supporting vital bodily functions. Examples include pacemakers, heart valves, and implantable defibrillators. These devices can restore or improve a patient's physical capabilities or organ function, significantly enhancing their quality of life which is expected to drive the segment growth.

By drug delivery devices, syringes is expected to show the highest CAGR of medical device contract manufacturing industry from 2024 to 2029.

The drug delivery devices market segment is segmented into infusion sets/administration sets, syringes, inhalers and autoinjectors & pedn injectors.

Syringes play a crucial role in various drug delivery devices, serving as a core component due to several advantages. Syringes can be adapted to deliver a wide range of drugs, including medications, vaccines, and fluids also the design of syringes allows for accurate measurement and administration of specific drug volumes, ensuring patients receive the intended dosage. which is expected to drive the market growth.

Asia Pacific accounted for the largest CAGR of the global medical device contract manufacturing industry, by region in the forecast period.

The medical device contract manufacturing market in Asia Pacific is expected to grow at the highest CAGR due to a combination of factors that highlight the region's changing healthcare landscape. Some APAC governments are promoting diagnostic health awareness and offering subsidies for several treatments, further stimulating market growth. The aging population in APAC is increasing the demand for medical devices to address several chronic diseases. Increasing wealth in APAC countries is leading to higher spending on healthcare, including medical device contract manufacturing.

The key players in the Medical device contract manufacturing market include Flex Ltd. (Singapore), Jabil Inc. (US), TE Connectivity Ltd. (Switzerland), Sanmina Corporation (US), Nipro Corporation (Japan), Celestica Inc. (Canada), Plexus Corp. (US), Integer Holdings Corporation (US), West Pharmaceutical Services, Inc. (US), Benchmark Electronics Inc. (US), Recipharm AB (Sweden), Gerresheimer AG (Germany), Kimball Electronics Inc. (US), Nortech Systems, Inc. (US), Nemera Development S.A. (France), Viant Medical Holdings, Inc. (US), Tecomet, Inc. (US), SMC Ltd. (US), Phillips-Medisize Corporation (US), Tessy Plastics Corp. (US), Carclo Plc (UK), Nolato GW, Inc. (US), MeHow (China), Tekni-Plex (US), and Peter’s Technology (China).

Scope of the Medical Device Contract Manufacturing Industry

Report Metric

Details

Market Revenue Size in 2024

$78.9 billion

Projected Revenue Size by 2029

$149.4 billion

Industry Growth Rate

Poised to Grow at a CAGR of 11.4%

Market Driver

Rising aging population

Market Opportunity

Potential for growth in emerging countries

The study categorizes the medical device contract manufacturing market to forecast revenue and analyze trends in each of the following submarkets:.

By Device Type
  • IVD Devices
    • IVD Consumables
    • IVD Equipment
  • Diagnostic Imaging Devices
  • Cardiovascular Devices
  • Drug Delivery Devices
    • Infusion Devices and Administration Sets
    • Syringes
    • Inhalers
    • Autoinjectors and Pen Injectors
  • Orthopedic Devices
  • Respiratory Care Devices
  • Ophthalmology Devices
  • Surgical Devices
  • Diabetes Care Devices
  • Dental Devices
  • Endoscopy and Laparoscopy Devices
  • Gynecology and Urology Devices
  • Personal Care Devices
  • Neurology Devices
  • Patient Monitoring Devices
  • Patient Assistive Devices
  • Other Devices
By Class of Device
  • Class I Medical Device
  • Class II Medical Device
  • Class III Medical Device
By Service
  • Device Development and Manufacturing Services
    • Device and Component Manufacturing
    • Process Development Services
    • Device Engineering Services
  • Quality Management Services
    • Packaging Validation Services
    • Inspection and Testing Services
    • Sterilization Services
  • Packaging and Assembly Services
    • Primary and Secondary Packaging
    • Labelling
    • Others
  • Other Services
By Region
  • Asia Pacific
    • China
    • Japan
    • Malaysia and Singapore
    • India
    • Australia and New Zealand
    • South Korea
    • Rest of Asia Pacific
  • North America
    • US
    • Canada
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East and Africa
  • GCC Countries

Recent Developments of Medical Device Contract Manufacturing Industry:

  • In November 2023, Jabil Inc. announced the successful acquisition of Retronix, an innovative provider in the reclamation and refurbishment of electronic components, completed earlier this year.
  • In January 2023, Integer announced the acquisition of Pulse Technologies, Inc., a privately held technology, engineering and contract manufacturing company focused on complex micro machining of medical device components for high growth structural heart, heart pump, electrophysiology, leadless pacing, and neuromodulation markets.
  • In January 2022, MixComm, the mmWave Antennas to Algorithms pioneer, announced it has selected Advanced Microsystems Technologies, a division of Sanmina as a lead partner to productize its 5G wireless infrastructure solutions
  • In November 2021, Nipro Corporation entered into a partnership with toyobo for cellulose triacetate (CTA) dialyzers (artificial kidneys).

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 52)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 REGIONS COVERED
           1.3.3 YEARS CONSIDERED
           1.3.4 CURRENCY CONSIDERED
                    TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
    1.4 STAKEHOLDERS 
    1.5 SUMMARY OF CHANGES 
           1.5.1 RECESSION IMPACT
 
2 RESEARCH METHODOLOGY (Page No. - 57)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
                                FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 6 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: FLEX, LTD.
          FIGURE 8 SUPPLY-SIDE ANALYSIS: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET (2023)
          FIGURE 9 DEMAND-SIDE ESTIMATION FOR MEDICAL DEVICE CONTRACT MANUFACTURING MARKET
          FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2029)
          FIGURE 11 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
          FIGURE 12 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ESTIMATION 
    2.5 STUDY ASSUMPTIONS 
    2.6 RESEARCH LIMITATIONS 
           2.6.1 METHODOLOGY-RELATED LIMITATIONS
           2.6.2 SCOPE-RELATED LIMITATIONS
    2.7 RISK ASSESSMENT 
          TABLE 2 RISK ASSESSMENT: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET
    2.8 RECESSION IMPACT ANALYSIS 
 
3 EXECUTIVE SUMMARY (Page No. - 73)
    FIGURE 14 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2024 VS. 2029 (USD MILLION)
    FIGURE 15 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2024 VS. 2029 (USD MILLION)
    FIGURE 16 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2024 VS. 2029 (USD MILLION)
    FIGURE 17 GEOGRAPHICAL SNAPSHOT OF MEDICAL DEVICE CONTRACT MANUFACTURING MARKET
 
4 PREMIUM INSIGHTS (Page No. - 77)
    4.1 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET OVERVIEW 
          FIGURE 18 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL DEVICE MODALITIES TO DRIVE MARKET
    4.2 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE AND COUNTRY (2023) 
          FIGURE 19 CLASS III MEDICAL DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2023
    4.3 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 
          FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
    4.4 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 21 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
    4.5 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: REGIONAL MIX 
          FIGURE 22 ASIA PACIFIC WILL CONTINUE TO DOMINATE MARKET IN 2029
 
5 MARKET OVERVIEW (Page No. - 82)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 23 MARKET DYNAMICS: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET
           5.2.1 DRIVERS
                    5.2.1.1 Growing medical devices market in developing countries
                                TABLE 3 GDP GROWTH FORECAST: COMPARISON OF INDIA, CHINA, US, AND GERMANY, 2020 VS. 2040 (FORECAST)
                    5.2.1.2 Adoption of robotics and automation in manufacturing
                    5.2.1.3 Technological advancements in medical device modalities
                                FIGURE 24 FACTORS DRIVING DEMAND FOR CONTRACT MANUFACTURING
                    5.2.1.4 Impact of Industry 4.0 on medical device industry
           5.2.2 RESTRAINTS
                    5.2.2.1 Consolidation in medical devices market
                                TABLE 4 KEY ACQUISITIONS IN MEDICAL DEVICE INDUSTRY
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing healthcare expenditure, infrastructure, and awareness in developing economies
                                TABLE 5 HEALTHCARE EXPENDITURE (%), BY COUNTRY (2010 TO 2021)
                                TABLE 6 HEALTHCARE EXPENDITURE PER CAPITA (USD),(2015 AND 2050)
                    5.2.3.2 Rising geriatric population and increasing incidence of associated diseases
                                TABLE 7 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION, 2019 VS. 2050
                                TABLE 8 AVERAGE LIFE EXPECTANCY, 2023 (FORECAST)
           5.2.4 CHALLENGES
                    5.2.4.1 Lack of constant innovation to balance technological capabilities against costs
           5.2.5 INDUSTRY TRENDS
                    5.2.5.1 Increasing consolidation of OEMs and contract manufacturers
                                TABLE 9 KEY EXAMPLES OF OEM CONSOLIDATION IN LAST FIVE YEARS
                                TABLE 10 KEY EXAMPLES OF CMO CONSOLIDATION
                    5.2.5.2 Growing interest of private equity firms in medical device contract manufacturing
                                TABLE 11 KEY INVESTMENTS BY PRIVATE EQUITY FIRMS
                    5.2.5.3 Outsourcing of medical device contract manufacturing services
                                TABLE 12 EXAMPLES OF KEY COLLABORATIONS AND AGREEMENTS
           5.2.6 INDUSTRY 5.0
    5.3 PRICING ANALYSIS 
           5.3.1 AVERAGE SELLING PRICE TREND FOR MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES, BY DEVICE
                    TABLE 13 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY DEVICE
           5.3.2 AVERAGE SELLING PRICE TREND, BY REGION
                    TABLE 14 AVERAGE COST RANGE OF MEDICAL DEVICE CONTRACT MANUFACTURING PRODUCTS, 2023 (USD)
    5.4 VALUE CHAIN ANALYSIS 
          FIGURE 25 VALUE CHAIN ANALYSIS: MEDICAL DEVICE CONTRACT MANUFACTURING (2023)
    5.5 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 15 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.5.1 THREAT OF NEW ENTRANTS
                    5.5.1.1 Growth in medical device industry
                    5.5.1.2 Demand for compact, cost-effective, and non-invasive devices
                    5.5.1.3 Consolidation
                    5.5.1.4 Poor financing environment
                    5.5.1.5 Stringent regulatory environment
           5.5.2 THREAT OF SUBSTITUTES
                    5.5.2.1 Undesirability of existing portfolios
                    5.5.2.2 Combination and integration of multiple technologies
                    5.5.2.3 Availability of alternatives
           5.5.3 BARGAINING POWER OF SUPPLIERS
                    5.5.3.1 Big medical device contract manufacturing companies
                    5.5.3.2 Institutional technology providers
                    5.5.3.3 Substantially innovative technologies
                    5.5.3.4 Dysfunctional companies
                    5.5.3.5 Academic inventors
           5.5.4 BARGAINING POWER OF BUYERS
                    5.5.4.1 Few buyers and many sellers
                    5.5.4.2 Buy-out threat
                    5.5.4.3 Demand for new pipeline services
                    5.5.4.4 Point of differentiation
           5.5.5 INTENSITY OF COMPETITIVE RIVALRY
                    5.5.5.1 Similar spectrum of services offered
                    5.5.5.2 Similar funding source
                    5.5.5.3 Self-funded big contract manufacturers
                    5.5.5.4 Highly fragmented industry
    5.6 TARIFF AND REGULATORY LANDSCAPE 
           5.6.1 REGULATORY ANALYSIS
                    5.6.1.1 North America
                               5.6.1.1.1 US
                                              TABLE 16 US: CLASSIFICATION OF MEDICAL EQUIPMENT
                                              TABLE 17 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                               5.6.1.1.2 Canada
                                              TABLE 18 CANADA: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                    5.6.1.2 Europe
                                TABLE 19 EUROPE: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                    5.6.1.3 Asia Pacific
                               5.6.1.3.1 Japan
                                              TABLE 20 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                               5.6.1.3.2 China
                                              TABLE 21 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                               5.6.1.3.3 India
           5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 22 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 23 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 24 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 25 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 26 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.7 KEY CONFERENCES AND EVENTS, 2024–2025 
          TABLE 27 DETAILED LIST OF CONFERENCES AND EVENTS
    5.8 PATENT ANALYSIS 
           5.8.1 PATENT PUBLICATION TRENDS FOR MEDICAL DEVICES
                    FIGURE 26 PATENT PUBLICATION TRENDS (JANUARY 2013–NOVEMBER 2023)
           5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
                    FIGURE 27 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR MEDICAL DEVICE PATENTS (JANUARY 2013–NOVEMBER 2023)
                    FIGURE 28 TOP 10 APPLICANT COUNTRIES/REGIONS FOR MEDICAL DEVICE PATENTS (JANUARY 2013–NOVEMBER 2023)
                    TABLE 28 MEDICAL DEVICES: LIST OF MAJOR PATENTS
    5.9 TECHNOLOGY ANALYSIS 
           5.9.1 KEY TECHNOLOGIES
                    5.9.1.1 Digital transformation
                    5.9.1.2 Robotics and automation
           5.9.2 ADJACENT TECHNOLOGIES
                    5.9.2.1 Artificial Intelligence
                    5.9.2.2 Big data
           5.9.3 COMPLEMENTARY TECHNOLOGIES
                    5.9.3.1 5G
    5.10 SUPPLY CHAIN ANALYSIS 
           FIGURE 29 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: SUPPLY CHAIN (2023)
    5.11 ECOSYSTEM ANALYSIS 
           TABLE 29 ROLE IN ECOSYSTEM: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, 2023
           FIGURE 30 ROLE IN ECOSYSTEM: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, 2023
    5.12 TRADE ANALYSIS 
           TABLE 30 IMPORT VALUE OF MEDICAL DEVICES FOR TOP 10 COUNTRIES IN 2023
           TABLE 31 EXPORT VALUE OF MEDICAL DEVICES FOR TOP 10 COUNTRIES IN 2023
    5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
           FIGURE 31 REVENUE SHIFTS IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET
    5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL DEVICES
                     TABLE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL DEVICES
           5.14.2 BUYING CRITERIA
                     FIGURE 33 KEY BUYING CRITERIA FOR MEDICAL DEVICES
                     TABLE 33 KEY BUYING CRITERIA FOR MEDICAL DEVICES
    5.15 ADJACENT MARKETS FOR MEDICAL DEVICE CONTRACT MANUFACTURING 
           FIGURE 34 ADJACENT MARKETS FOR MEDICAL DEVICE CONTRACT MANUFACTURING
    5.16 UNMET NEEDS/END-USER EXPECTATIONS IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 
    5.17 APPLICATION OF ARTIFICIAL INTELLIGENCE IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 
    5.18 CASE STUDY ANALYSIS 
           5.18.1 JABIL INC. AND HEARTWARE INTERNATIONAL
           5.18.2 FLEX LTD. IN MEDICAL DEVICE MANUFACTURING
           5.18.3 BRINGING AN INNOVATIVE INSULIN PUMP TO MARKET
    5.19 INVESTMENT AND FUNDING SCENARIO 
           TABLE 34 INVESTMENT/VENTURE CAPITAL SCENARIO IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, 2018–2022
 
6 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE (Page No. - 122)
    6.1 INTRODUCTION 
          TABLE 35 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
    6.2 IVD DEVICES 
          TABLE 36 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
          TABLE 37 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY COUNTRY, 2021–2029 (USD MILLION)
           6.2.1 IVD CONSUMABLES
                    6.2.1.1 Increasing demand for reagents & kits to drive market
                                TABLE 38 IVD CONSUMABLES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
           6.2.2 IVD EQUIPMENT
                    6.2.2.1 Advances in life sciences research to support market growth
                                TABLE 39 IVD EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
    6.3 DIAGNOSTIC IMAGING DEVICES 
           6.3.1 ADOPTION OF NEW AND ADVANCED DIAGNOSTIC IMAGING SYSTEMS IN DEVELOPING COUNTRIES TO SUPPORT MARKET GROWTH
                    TABLE 40 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DIAGNOSTIC IMAGING DEVICES, BY COUNTRY, 2021–2029 (USD MILLION)
    6.4 CARDIOVASCULAR DEVICES 
           6.4.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO PROPEL MARKET
                    TABLE 41 PREVALENCE OF CARDIOVASCULAR DISEASES, 2015–2035
                    TABLE 42 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CARDIOVASCULAR DEVICES, BY COUNTRY, 2021–2029 (USD MILLION)
    6.5 DRUG DELIVERY DEVICES 
          TABLE 43 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
          TABLE 44 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY COUNTRY, 2021–2029 (USD MILLION)
           6.5.1 INFUSION DEVICES & ADMINISTRATION SETS
                    6.5.1.1 Rising incidence of chronic diseases to fuel market growth
                                TABLE 45 INFUSION DEVICES AND ADMINISTRATION SETS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
           6.5.2 SYRINGES
                    6.5.2.1 Increasing incidence of needlestick injuries to hamper market growth
                                TABLE 46 SYRINGES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
           6.5.3 INHALERS
                    6.5.3.1 High prevalence of asthma, COPD, and cystic fibrosis to aid market growth
                                TABLE 47 INHALERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
           6.5.4 AUTOINJECTORS & PEN INJECTORS
                    6.5.4.1 Rising number of regulatory approvals for new drug therapies to support market growth
                                TABLE 48 RECENT APPROVALS FOR AUTOINJECTORS AND PEN INJECTORS GLOBALLY
                                TABLE 49 AUTOINJECTORS & PEN INJECTORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
    6.6 ORTHOPEDIC DEVICES 
           6.6.1 HIGH PREVALENCE OF ORTHOPEDIC CONDITIONS TO DRIVE MARKET
                    TABLE 50 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR ORTHOPEDIC DEVICES, BY COUNTRY, 2021–2029 (USD MILLION)
    6.7 RESPIRATORY CARE DEVICES 
           6.7.1 COVID-19 BOOSTED DEMAND FOR CONTRACT MANUFACTURING OF RESPIRATORY CARE DEVICES
                    TABLE 51 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR RESPIRATORY CARE DEVICES, BY COUNTRY, 2021–2029 (USD MILLION)
    6.8 OPHTHALMOLOGY DEVICES 
           6.8.1 INCREASING PREVALENCE OF OPHTHALMIC DISEASES TO DRIVE MARKET
                    TABLE 52 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR OPHTHALMOLOGY DEVICES, BY COUNTRY, 2021–2029 (USD MILLION)
    6.9 SURGICAL DEVICES 
           6.9.1 INCREASING NUMBER OF SURGICAL PROCEDURES TO FUEL MARKET GROWTH
                    TABLE 53 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR SURGICAL DEVICES, BY COUNTRY, 2021–2029 (USD MILLION)
    6.10 DIABETES CARE DEVICES 
           6.10.1 RISING PREVALENCE OF DIABETES TO PROPEL MARKET
                     TABLE 54 TOP FIVE COUNTRIES WITH HIGHEST NUMBER OF DIABETICS (20–79 YEARS), 2021 VS. 2045
                     TABLE 55 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DIABETES CARE DEVICES, BY COUNTRY, 2021–2029 (USD MILLION)
    6.11 DENTAL DEVICES 
           6.11.1 RISING INCIDENCE OF DENTAL DISORDERS TO SUPPORT MARKET GROWTH
                     TABLE 56 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DENTAL DEVICES, BY COUNTRY, 2021–2029 (USD MILLION)
    6.12 ENDOSCOPY & LAPAROSCOPY DEVICES 
           6.12.1 RISING PATIENT PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO AUGMENT MARKET
                     TABLE 57 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR ENDOSCOPY & LAPAROSCOPY DEVICES, BY COUNTRY, 2021–2029 (USD MILLION)
    6.13 GYNECOLOGY/UROLOGY DEVICES 
           6.13.1 GROWING AWARENESS AND PREVENTIVE CHECKUPS FOR LATE-PHASE DIAGNOSIS OF STDS TO PROPEL MARKET
                     FIGURE 35 US: SEXUALLY TRANSMITTED DISEASE CASES, 2017 VS. 2021
                     TABLE 58 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR GYNECOLOGY/UROLOGY DEVICES, BY COUNTRY, 2021–2029 (USD MILLION)
    6.14 PERSONAL CARE DEVICES 
           6.14.1 SHIFT IN CONSUMPTION PATTERN TOWARD PREMIUM PERSONAL CARE PRODUCTS TO FUEL MARKET
                     TABLE 59 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PERSONAL CARE DEVICES, BY COUNTRY, 2021–2029 (USD MILLION)
    6.15 NEUROLOGY DEVICES 
           6.15.1 RISING PREVALENCE OF NEUROLOGICAL DISEASES TO DRIVE MARKET
                     TABLE 60 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR NEUROLOGY DEVICES, BY COUNTRY, 2021–2029 (USD MILLION)
    6.16 PATIENT MONITORING DEVICES 
           6.16.1 GROWING AVAILABILITY OF INTEGRATED MONITORING TECHNOLOGY TO AID MARKET
                     TABLE 61 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PATIENT MONITORING DEVICES, BY COUNTRY, 2021–2029 (USD MILLION)
    6.17 PATIENT ASSISTIVE DEVICES 
           6.17.1 RISING GERIATRIC POPULATION TO PROPEL MARKET
                     TABLE 62 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PATIENT ASSISTIVE DEVICES, BY COUNTRY, 2021–2029 (USD MILLION)
    6.18 OTHER DEVICES 
           TABLE 63 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR OTHER DEVICES, BY COUNTRY, 2021–2029 (USD MILLION)
 
7 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE (Page No. - 168)
    7.1 INTRODUCTION 
          TABLE 64 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
    7.2 COMPARISON OF DEVICE CLASSIFICATION, BY COUNTRY/REGION 
           7.2.1 US
                    7.2.1.1 Class I: General controls
                    7.2.1.2 Class II: General controls with special controls
                    7.2.1.3 Class III: General controls, special controls, and premarket approval
           7.2.2 CANADA
           7.2.3 EUROPEAN UNION AND EUROPEAN FREE TRADE ASSOCIATION
                    7.2.3.1 Class I medical devices
                               7.2.3.1.1 Class Is: Noninvasive devices
                               7.2.3.1.2 Class Ir: Reusable surgical instruments
                               7.2.3.1.3 Class Im: Low-risk measuring devices
                    7.2.3.2 Class IIa medical devices
                    7.2.3.3 Class IIb medical devices
                    7.2.3.4 Class III medical devices
           7.2.4 ASIA PACIFIC
                    7.2.4.1 China
                    7.2.4.2 India
                    7.2.4.3 Japan
                    7.2.4.4 Australia
    7.3 CLASS II MEDICAL DEVICES 
           7.3.1 HIGH-VOLUME UTILIZATION OF CLASS II MEDICAL DEVICES BY END USERS TO SUPPORT MARKET GROWTH
                    TABLE 65 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CLASS II MEDICAL DEVICES, BY COUNTRY, 2021–2029 (USD MILLION)
    7.4 CLASS I MEDICAL DEVICES 
           7.4.1 POSSESS MINIMUM POTENTIAL TO HARM USERS
                    TABLE 66 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CLASS I MEDICAL DEVICES, BY COUNTRY, 2021–2029 (USD MILLION)
    7.5 CLASS III MEDICAL DEVICES 
           7.5.1 INVOLVE HIGHEST LEVEL OF HEALTH RISKS TO USERS
                    TABLE 67 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CLASS III MEDICAL DEVICES, BY COUNTRY, 2021–2029 (USD MILLION)
 
8 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE (Page No. - 180)
    8.1 INTRODUCTION 
          FIGURE 36 STAGES INVOLVED IN CONTRACT MANUFACTURING OF MEDICAL DEVICES
          TABLE 68 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
    8.2 DEVICE DEVELOPMENT AND MANUFACTURING 
          TABLE 69 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
          TABLE 70 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY COUNTRY, 2021–2029 (USD MILLION)
           8.2.1 DEVICE AND COMPONENT MANUFACTURING
                    8.2.1.1 Development of new technologies necessitates specialized device manufacturing capabilities
                                TABLE 71 DEVICE AND COMPONENT MANUFACTURING SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
           8.2.2 PROCESS DEVELOPMENT
                    8.2.2.1 Growing demand for complex products to drive growth
                                FIGURE 37 PROCESS DEVELOPMENT SERVICES FOR MEDICAL DEVICES
                                TABLE 72 PROCESS DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
           8.2.3 DEVICE ENGINEERING
                    8.2.3.1 Efficiency and cost-effectiveness of device engineering services to propel segment
                                TABLE 73 DEVICE ENGINEERING SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
    8.3 QUALITY MANAGEMENT 
          TABLE 74 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
          TABLE 75 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY COUNTRY, 2021–2029 (USD MILLION)
           8.3.1 PACKAGING VALIDATION
                    8.3.1.1 Increasing product safety concerns for medical devices to aid market
                                TABLE 76 PACKAGING VALIDATION SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
           8.3.2 INSPECTION AND TESTING
                    8.3.2.1 Increased technological expertise in testing services to eliminate large capital and overhead investments
                                TABLE 77 INSPECTION AND TESTING SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
           8.3.3 STERILIZATION SERVICES
                    8.3.3.1 Need to meet regulatory requirements for sterility in medical devices to support market growth
                                TABLE 78 MEDICAL DEVICE STERILIZATION PATENTS PUBLISHED BY MAJOR COMPANIES WORLDWIDE
                                TABLE 79 STERILIZATION SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
    8.4 PACKAGING AND ASSEMBLY SERVICES 
          FIGURE 38 FINAL ASSEMBLY SERVICES IN GLOBAL VALUE CHAIN OF MEDICAL DEVICES
          TABLE 80 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
          TABLE 81 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY COUNTRY, 2021–2029 (USD MILLION)
           8.4.1 PRIMARY AND SECONDARY PACKAGING
                    8.4.1.1 Growing concerns for patient safety to aid growth
                                TABLE 82 PRIMARY AND SECONDARY PACKAGING SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
           8.4.2 LABELING
                    8.4.2.1 Export bans and product recalls due to improper labeling to support market
                                TABLE 83 LABELING SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
           8.4.3 OTHER PACKAGING AND ASSEMBLY SERVICES
                    TABLE 84 OTHER PACKAGING AND ASSEMBLY SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
    8.5 OTHER SERVICES 
          TABLE 85 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR OTHER SERVICES, BY COUNTRY, 2021–2029 (USD MILLION)
 
9 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY REGION (Page No. - 204)
    9.1 INTRODUCTION 
          FIGURE 39 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
          TABLE 86 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2029 (USD MILLION)
    9.2 ASIA PACIFIC 
           9.2.1 ASIA PACIFIC: RECESSION IMPACT
                    FIGURE 40 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET SNAPSHOT
                    TABLE 87 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 88 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                    TABLE 89 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 90 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 91 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                    TABLE 92 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                    TABLE 93 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 94 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 95 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
           9.2.2 CHINA
                    9.2.2.1 Low labor costs and rapidly changing healthcare infrastructure to drive market
                                TABLE 96 CHINA: KEY MACROINDICATORS
                                TABLE 97 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                                TABLE 98 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 99 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 100 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                                TABLE 101 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                                TABLE 102 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 103 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 104 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
           9.2.3 JAPAN
                    9.2.3.1 Universal healthcare reimbursement policies to propel market
                                TABLE 105 JAPAN: KEY MACROINDICATORS
                                TABLE 106 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                                TABLE 107 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 108 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 109 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                                TABLE 110 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                                TABLE 111 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 112 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 113 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
           9.2.4 MALAYSIA & SINGAPORE
                    9.2.4.1 Increasing R&D activities and investments by established players to augment market
                                TABLE 114 MALAYSIA: KEY MACROINDICATORS
                                TABLE 115 SINGAPORE: KEY MACROINDICATORS
                                TABLE 116 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                                TABLE 117 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 118 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 119 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                                TABLE 120 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                                TABLE 121 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 122 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 123 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
           9.2.5 INDIA
                    9.2.5.1 Rising contract manufacturing capabilities to support market growth
                                TABLE 124 INDIA: KEY MACROINDICATORS
                                TABLE 125 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                                TABLE 126 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 127 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 128 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                                TABLE 129 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                                TABLE 130 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 131 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 132 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
           9.2.6 AUSTRALIA & NEW ZEALAND
                    9.2.6.1 Need for advanced medical and diagnostic tools to fuel market growth
                                TABLE 133 AUSTRALIA: KEY MACROINDICATORS
                                TABLE 134 NEW ZEALAND: KEY MACROINDICATORS
                                TABLE 135 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                                TABLE 136 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 137 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 138 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                                TABLE 139 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                                TABLE 140 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 141 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 142 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
           9.2.7 SOUTH KOREA
                    9.2.7.1 High-value imports from other countries to offer growth opportunities
                                TABLE 143 SOUTH KOREA: KEY MACROINDICATORS
                                TABLE 144 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                                TABLE 145 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 146 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 147 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                                TABLE 148 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                                TABLE 149 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 150 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 151 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
           9.2.8 REST OF ASIA PACIFIC
                    TABLE 152 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                    TABLE 153 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 154 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 155 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                    TABLE 156 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                    TABLE 157 REST OF ASIA PACIFIC: DEVICE DEVELOPMENT & MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 158 REST OF ASIA PACIFIC: QUALITY MANAGEMENT SERVICES MARKET, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 159 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
    9.3 NORTH AMERICA 
           9.3.1 NORTH AMERICA: RECESSION IMPACT
                    TABLE 160 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 161 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                    TABLE 162 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 163 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 164 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                    TABLE 165 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                    TABLE 166 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 167 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 168 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
           9.3.2 US
                    9.3.2.1 Presence of stringent government regulations to drive market
                                TABLE 169 US: KEY MACROINDICATORS
                                TABLE 170 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                                TABLE 171 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 172 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 173 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                                TABLE 174 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                                TABLE 175 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 176 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 177 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
           9.3.3 CANADA
                    9.3.3.1 Strong presence of key contract manufacturing companies to augment market
                                TABLE 178 CANADA: KEY MACROINDICATORS
                                TABLE 179 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                                TABLE 180 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 181 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 182 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                                TABLE 183 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                                TABLE 184 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 185 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 186 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
    9.4 EUROPE 
           9.4.1 EUROPE: RECESSION IMPACT
                    TABLE 187 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 188 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                    TABLE 189 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 190 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 191 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                    TABLE 192 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                    TABLE 193 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 194 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 195 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
           9.4.2 GERMANY
                    9.4.2.1 Presence of major device manufacturers and high healthcare expenditure to support market growth
                                TABLE 196 GERMANY: KEY MACROINDICATORS
                                TABLE 197 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                                TABLE 198 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 199 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 200 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                                TABLE 201 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                                TABLE 202 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT & MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 203 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 204 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
           9.4.3 FRANCE
                    9.4.3.1 Increasing government pressure for healthcare cost reduction and budgetary constraints to support market growth
                                TABLE 205 FRANCE: KEY MACROINDICATORS
                                TABLE 206 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                                TABLE 207 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 208 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 209 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                                TABLE 210 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                                TABLE 211 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 212 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 213 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
           9.4.4 UK
                    9.4.4.1 Rising number of accredited clinical laboratories and hospital laboratories to propel market
                                TABLE 214 UK: KEY MACROINDICATORS
                                TABLE 215 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                                TABLE 216 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 217 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 218 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                                TABLE 219 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                                TABLE 220 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 221 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 222 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
           9.4.5 ITALY
                    9.4.5.1 Healthcare coverage for all citizens and foreign residents to increase demand for medical devices
                                TABLE 223 ITALY: KEY MACROINDICATORS
                                TABLE 224 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                                TABLE 225 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 226 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 227 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                                TABLE 228 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                                TABLE 229 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 230 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 231 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
           9.4.6 SPAIN
                    9.4.6.1 Increasing adoption of home-based medical devices to drive market
                                TABLE 232 SPAIN: KEY MACROINDICATORS
                                TABLE 233 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                                TABLE 234 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 235 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 236 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                                TABLE 237 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                                TABLE 238 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 239 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 240 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
           9.4.7 REST OF EUROPE
                    TABLE 241 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                    TABLE 242 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 243 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 244 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                    TABLE 245 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                    TABLE 246 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 247 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 248 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
    9.5 LATIN AMERICA 
           9.5.1 LATIN AMERICA: RECESSION IMPACT
                    TABLE 249 LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
                    TABLE 250 LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                    TABLE 251 LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 252 LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 253 LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                    TABLE 254 LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                    TABLE 255 LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 256 LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 257 LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
           9.5.2 MEXICO
                    9.5.2.1 Important destination for contract manufacturers
                                TABLE 258 MEXICO: KEY MACROINDICATORS
                                TABLE 259 MEXICO: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                                TABLE 260 MEXICO: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 261 MEXICO: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 262 MEXICO: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                                TABLE 263 MEXICO: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                                TABLE 264 MEXICO: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 265 MEXICO: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 266 MEXICO: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
           9.5.3 BRAZIL
                    9.5.3.1 Favorable government initiatives and willingness to pay for better healthcare to boost market
                                TABLE 267 BRAZIL: KEY MACROINDICATORS
                                TABLE 268 BRAZIL: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                                TABLE 269 BRAZIL: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 270 BRAZIL: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 271 BRAZIL: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                                TABLE 272 BRAZIL: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                                TABLE 273 BRAZIL: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 274 BRAZIL: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                                TABLE 275 BRAZIL: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
           9.5.4 REST OF LATIN AMERICA
                    TABLE 276 REST OF LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                    TABLE 277 REST OF LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 278 REST OF LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 279 REST OF LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                    TABLE 280 REST OF LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                    TABLE 281 REST OF LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 282 REST OF LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 283 REST OF LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
    9.6 MIDDLE EAST & AFRICA 
           9.6.1 GROWING HEALTHCARE INVESTMENTS AND IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
           9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
                    TABLE 284 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                    TABLE 285 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 286 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 287 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                    TABLE 288 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                    TABLE 289 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 290 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 291 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
    9.7 GCC COUNTRIES 
           9.7.1 INCREASING HEALTHCARE INFRASTRUCTURE DEVELOPMENT TO SUPPORT MARKET GROWTH
           9.7.2 GCC COUNTRIES: RECESSION IMPACT
                    TABLE 292 GCC COUNTRIES: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION)
                    TABLE 293 GCC COUNTRIES: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 294 GCC COUNTRIES: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 295 GCC COUNTRIES: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION)
                    TABLE 296 GCC COUNTRIES: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION)
                    TABLE 297 GCC COUNTRIES: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 298 GCC COUNTRIES: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION)
                    TABLE 299 GCC COUNTRIES: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION)
 
10 COMPETITIVE LANDSCAPE (Page No. - 322)
     10.1 OVERVIEW 
             10.1.1 KEY PLAYER STRATEGIES/RIGHT TO WIN
                        TABLE 300 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MEDICAL DEVICE CONTRACT MANUFACTURERS
     10.2 REVENUE SHARE ANALYSIS 
             FIGURE 41 REVENUE SHARE ANALYSIS FOR KEY COMPANIES, 2020–2023
     10.3 MARKET SHARE ANALYSIS 
             FIGURE 42 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)
             TABLE 301 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: DEGREE OF COMPETITION
     10.4 COMPANY EVALUATION MATRIX: KEY PLAYERS 
             10.4.1 STARS
             10.4.2 EMERGING LEADERS
             10.4.3 PERVASIVE PLAYERS
             10.4.4 PARTICIPANTS
                        FIGURE 43 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
             10.4.5 COMPETITIVE FOOTPRINT
                        FIGURE 44 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: OVERALL COMPANY FOOTPRINT
                        TABLE 302 DEVICE FOOTPRINT (1/2)
                        TABLE 303 DEVICE FOOTPRINT (2/2)
                        TABLE 304 CLASS OF DEVICE FOOTPRINT
                        TABLE 305 SERVICE FOOTPRINT
                        TABLE 306 REGIONAL FOOTPRINT
     10.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES 
             10.5.1 PROGRESSIVE COMPANIES
             10.5.2 DYNAMIC COMPANIES
             10.5.3 STARTING BLOCKS
             10.5.4 RESPONSIVE COMPANIES
                        FIGURE 45 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: COMPANY EVALUATION MATRIX (SMES/STARTUPS), 2023
             10.5.5 COMPETITIVE BENCHMARKING
                        TABLE 307 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: DETAILED LIST OF KEY STARTUP/SMES
                        TABLE 308 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SMES
     10.6 R&D EXPENDITURE OF KEY PLAYERS 
             FIGURE 46 MEDICAL DEVICE MANUFACTURING MARKET: R&D EXPENDITURE OF KEY PLAYERS, 2021–2023
     10.7 COMPETITIVE SCENARIO 
             10.7.1 PRODUCT LAUNCHES & APPROVALS
                        TABLE 309 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
             10.7.2 DEALS
                        TABLE 310 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: DEALS (JANUARY 2020– DECEMBER 2023)
             10.7.3 EXPANSIONS
                        TABLE 311 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: EXPANSIONS (JANUARY 2020– DECEMBER 2023)
             10.7.4 OTHER DEVELOPMENTS
                        TABLE 312 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023)
             10.7.5 BRAND/PRODUCT COMPARATIVE ANALYSIS
                        FIGURE 47 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY DEVICE
                        10.7.5.1 Jabil Inc.
                        10.7.5.2 Flex Ltd.
                        10.7.5.3 Sanmina Corporation
                        10.7.5.4 Integer Holdings Corporation
                        10.7.5.5 Plexus Corp.
                        10.7.5.6 Nipro Corporation
                        10.7.5.7 TE Connectivity Ltd.
             10.7.6 INVESTMENT LANDSCAPE
                        FIGURE 48 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FUNDING SOARED IN 2022
                        FIGURE 49 MOST VALUED MEDICAL DEVICE CONTRACT MANUFACTURING FIRMS IN 2022 (USD BILLION)
                        FIGURE 50 VALUATION AND FINANCIAL METRICS OF KEY MEDICAL DEVICE CONTRACT MANUFACTURING VENDORS
 
11 COMPANY PROFILES (Page No. - 347)
     11.1 KEY PLAYERS 
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
             11.1.1 JABIL INC.
                        TABLE 313 JABIL INC.: COMPANY OVERVIEW
                        FIGURE 51 JABIL INC.: COMPANY SNAPSHOT (2023)
                        TABLE 314 JABIL INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 315 JABIL INC.: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 316 JABIL INC.: DEALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 317 JABIL INC.: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
             11.1.2 FLEX LTD.
                        TABLE 318 FLEX LTD.: COMPANY OVERVIEW
                        FIGURE 52 FLEX LTD.: COMPANY SNAPSHOT (2023)
                        TABLE 319 FLEX LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 320 FLEX LTD.: DEALS (JANUARY 2020–DECEMBER 2023)
             11.1.3 PLEXUS CORP.
                        TABLE 321 PLEXUS CORP.: COMPANY OVERVIEW
                        FIGURE 53 PLEXUS CORP.: COMPANY SNAPSHOT (2023)
                        TABLE 322 PLEXUS CORP.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 323 PLEXUS CORP.: DEALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 324 PLEXUS CORP.: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
             11.1.4 SANMINA CORPORATION
                        TABLE 325 SANMINA CORPORATION: COMPANY OVERVIEW
                        FIGURE 54 SANMINA CORPORATION: COMPANY SNAPSHOT (2023)
                        TABLE 326 SANMINA CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 327 SANMINA CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 328 SANMINA CORPORATION: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
                        TABLE 329 SANMINA CORPORATION: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023)
             11.1.5 INTEGER HOLDINGS CORPORATION
                        TABLE 330 INTEGER HOLDINGS CORPORATION: COMPANY OVERVIEW
                        FIGURE 55 INTEGER HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022)
                        TABLE 331 INTEGER HOLDINGS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 332 INTEGER HOLDINGS CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 333 INTEGER HOLDINGS CORPORATION: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
             11.1.6 TE CONNECTIVITY LTD.
                        TABLE 334 TE CONNECTIVITY LTD.: COMPANY OVERVIEW
                        FIGURE 56 TE CONNECTIVITY LTD.: COMPANY SNAPSHOT (2023)
                        TABLE 335 TE CONNECTIVITY LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 336 TE CONNECTIVITY LTD.: SERVICE LAUNCHES (JANUARY 2020–DECEMBER 2023)
                        TABLE 337 TE CONNECTIVITY LTD.: DEALS (JANUARY 2020–DECEMBER 2023)
             11.1.7 NIPRO CORPORATION
                        TABLE 338 NIPRO CORPORATION: COMPANY OVERVIEW
                        FIGURE 57 NIPRO CORPORATION: COMPANY SNAPSHOT (2023)
                        TABLE 339 NIPRO CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 340 NIPRO CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 341 NIPRO CORPORATION: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
             11.1.8 CELESTICA INC.
                        TABLE 342 CELESTICA INC.: COMPANY OVERVIEW
                        FIGURE 58 CELESTICA INC.: COMPANY SNAPSHOT (2022)
                        TABLE 343 CELESTICA INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 344 CELESTICA INC.: DEALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 345 CELESTICA INC.: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
                        TABLE 346 CELESTICA INC.: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023)
             11.1.9 WEST PHARMACEUTICAL SERVICES, INC.
                        TABLE 347 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY OVERVIEW
                        FIGURE 59 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT (2022)
                        TABLE 348 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 349 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
                        TABLE 350 WEST PHARMACEUTICAL SERVICES, INC.: DEALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 351 WEST PHARMACEUTICAL SERVICES, INC.: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
             11.1.10 BENCHMARK ELECTRONICS INC.
                        TABLE 352 BENCHMARK ELECTRONICS INC.: COMPANY OVERVIEW
                        FIGURE 60 BENCHMARK ELECTRONICS INC.: COMPANY SNAPSHOT (2022)
                        TABLE 353 BENCHMARK ELECTRONICS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 354 BENCHMARK ELECTRONICS INC.: DEALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 355 BENCHMARK ELECTRONICS INC.: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
             11.1.11 RECIPHARM AB
                        TABLE 356 RECIPHARM AB: COMPANY OVERVIEW
                        TABLE 357 RECIPHARM AB: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 358 RECIPHARM AB: DEALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 359 RECIPHARM AB: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
                        TABLE 360 RECIPHARM AB: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023)
             11.1.12 GERRESHEIMER AG
                        TABLE 361 GERRESHEIMER AG.: COMPANY OVERVIEW
                        FIGURE 61 GERRESHEIMER AG: COMPANY SNAPSHOT (2022)
                        TABLE 362 GERRESHEIMER AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 363 GERRESHEIMER AG: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
                        TABLE 364 GERRESHEIMER AG: DEALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 365 GERRESHEIMER AG: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
                        TABLE 366 GERRESHEIMER AG.: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023)
             11.1.13 KIMBALL ELECTRONICS, INC.
                        TABLE 367 KIMBALL ELECTRONICS, INC.: COMPANY OVERVIEW
                        FIGURE 62 KIMBALL ELECTRONICS, INC.: COMPANY SNAPSHOT (2023)
                        TABLE 368 KIMBALL ELECTRONICS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 369 KIMBALL ELECTRONICS, INC.: SERVICE LAUNCHES (JANUARY 2020–DECEMBER 2023)
                        TABLE 370 KIMBALL MEDICAL SOLUTIONS: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023)
             11.1.14 NORTECH SYSTEMS INCORPORATED
                        TABLE 371 NORTECH SYSTEMS INCORPORATED: COMPANY OVERVIEW
                        FIGURE 63 NORTECH SYSTEMS INCORPORATED: COMPANY SNAPSHOT (2022)
                        TABLE 372 NORTECH SYSTEMS INCORPORATED: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 373 NORTECH SYSTEMS INCORPORATED: DEALS (JANUARY 2020–DECEMBER 2023)
             11.1.15 CARCLO PLC
                        TABLE 374 CARCLO PLC: COMPANY OVERVIEW
                        FIGURE 64 CARCLO PLC: COMPANY SNAPSHOT (2023)
                        TABLE 375 CARCLO PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
             11.1.16 NOLATO GW, INC. (NOLATO AB)
                        TABLE 376 NOLATO GW, INC.: COMPANY OVERVIEW
                        FIGURE 65 NOLATO GW, INC.: COMPANY SNAPSHOT (2023)
                        TABLE 377 NOLATO GW, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 378 NOLATO GW, INC.: DEALS (JANUARY 2020–DECEMBER 2023)
     11.2 OTHER PLAYERS 
             11.2.1 NEMERA
                        TABLE 379 NEMERA: COMPANY OVERVIEW
                        TABLE 380 NEMERA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 381 NEMERA: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
                        TABLE 382 NEMERA: DEALS (JANUARY 2020–DECEMBER 2023)
             11.2.2 VIANT MEDICAL HOLDINGS, INC.
                        TABLE 383 VIANT MEDICAL HOLDINGS, INC.: COMPANY OVERVIEW
                        TABLE 384 VIANT MEDICAL HOLDINGS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 385 VIANT MEDICAL HOLDINGS, INC.: DEALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 386 VIANT MEDICAL HOLDINGS, INC.: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
             11.2.3 TECOMET, INC.
                        TABLE 387 TECOMET INC.: COMPANY OVERVIEW
                        TABLE 388 TECOMET INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 389 TECOMET INC.: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
             11.2.4 SMC LTD.
                        TABLE 390 SMC LTD.: COMPANY OVERVIEW
                        TABLE 391 SMC LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 392 SMC LTD.: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
             11.2.5 PHILLIPS-MEDISIZE CORPORATION
                        TABLE 393 PHILLIPS-MEDISIZE CORPORATION: COMPANY OVERVIEW
                        TABLE 394 PHILLIPS-MEDISIZE CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 395 PHILLIPS-MEDISIZE CORPORATION: PRODUCT LAUNCHES (JANUARY 2021-DECEMBER 2021)
                        TABLE 396 PHILLIPS-MEDISIZE CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
                        TABLE 397 PHILLIPS-MEDISIZE CORPORATION: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
             11.2.6 TESSY PLASTICS CORP.
                        TABLE 398 TESSY PLASTICS CORP.: COMPANY OVERVIEW
                        TABLE 399 TESSY PLASTICS CORP.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 400 TESSY PLASTICS CORP.: DEALS
             11.2.7 MEHOW
                        TABLE 401 MEHOW: COMPANY OVERVIEW
                        TABLE 402 MEHOW: PRODUCTS/SERVICES/SOLUTIONS OFFERED
             11.2.8 TEKNI-PLEX
                        TABLE 403 TEKNI-PLEX: COMPANY OVERVIEW
                        TABLE 404 TEKNI-PLEX: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 405 TEKNI-PLEX: DEALS (JANUARY 2020–DECEMBER 2023)
             11.2.9 PETER’S TECHNOLOGY
                        TABLE 406 PETER’S TECHNOLOGY: COMPANY OVERVIEW
                        TABLE 407 PETER’S TECHNOLOGY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
 
12 APPENDIX (Page No. - 437)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS 

The study involved four major activities in estimating the current size of the medical device contract manufacturing market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the medical device contract manufacturing market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the medical device contract manufacturing market. The primary sources from the demand side included industry experts, purchase & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.

A breakdown of the primary respondents for the medical device contract manufacturing market is provided below:

Medical Device Contract Manufacturing Market Size, and Share

Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

Note 2: Other primaries include Others include sales managers, marketing managers, and product managers.

Note 3: Companies are classified into tiers based on their total revenue. As of 2020: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=<USD 500 million

To know about the assumptions considered for the study, download the pdf brochure

The research methodology used to estimate the size of the medical device contract manufacturing market includes the following details.

The market sizing of the market was undertaken from the global side.

Country-level Analysis: The size of the medical device contract manufacturing market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products and services in the overall medical device contract manufacturing market was obtained from secondary data and validated by primary participants to arrive at the total medical device contract manufacturing market. Primary participants further validated the numbers.

Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall medical device contract manufacturing market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

Global Medical device contract manufacturing Size: Top-Down Approach

Medical Device Contract Manufacturing Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Medical device contract manufacturing Size: Bottom-Up Approach

Medical Device Contract Manufacturing Market Size, and Share

Data Triangulation

After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Medical Device Contract Manufacturing is a process where a MedTech company that owns the idea (sole proprietorship) outsources manufacturing to another Medical device manufacturing firm. The product is developed according to the specifications sent by the OEM company in compliance with ISO:13485 and FDA guidelines.

Key Stakeholders

  • Manufacturers and distributors of medical devices
  • Manufacturers and distributors of medical device components
  • Medical device contract manufacturing companies
  • Healthcare institutes
  • Diagnostic laboratories
  • Hospitals and clinics
  • Academic institutes
  • Research institutes
  • Government associations
  • Market research and consulting firms
  • Venture capitalists and investors

Objectives of the Study

  • To define, describe, segment, analyze, and forecast the global medical device contract manufacturing market by device type, class of device, service and region
  • To provide detailed information about the factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets concerning individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
  • To forecast the size of the medical device contract manufacturing market in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa and GCC countries.
  • To profile the key players in the medical device contract manufacturing market and comprehensively analyze their core competencies.
  • To track and analyze competitive developments such as agreements, collaborations, and partnerships; expansions; acquisitions; and product launches and approvals in the medical device contract manufacturing market.
  • To analyze the impact of the recession on the medical device contract manufacturing market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific medical device contract manufacturing market into Indonesia, Philippines, Vietnam, Hong Kong, and other countries
  • Further breakdown of the Rest of Europe medical device contract manufacturing market into Belgium, Russia, the Netherlands, Switzerland, and other countries.
  • Further breakdown of the Rest of Latin America medical device contract manufacturing market into Argentina, Peru, and other countries.
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 7111
Published ON
Mar, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Medical Device Contract Manufacturing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
Website Feedback